Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera

Journal of Immunological Methods

Volumn 433, Issue , 2016, Pages 1-5

  Cavazzana, Ilaria ^a   Fredi, Micaela ^a   Ceribelli, Angela ^b   Mordenti, Cristina ^a   Ferrari, Fabio ^a   Carabellese, Nice ^a   Tincani, Angela ^a   Satoh, Minoru ^c   Franceschini, Franco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Anti Jo1; Anti synthetase syndrome; Autoantibodies; Immunoprecipitation; Line blot; Myositis

Indexed keywords

AUTOANTIBODY; CELL EXTRACT; ISOTOPE; JO 1 ANTIBODY; MDA5 ANTIBODY; METHIONINE S 35; NXP 2 ANTIBODY; TIF1 GAMMA ANTIBODY; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; ANTINUCLEAR ANTIBODY; DNA BINDING PROTEIN; IFIH1 PROTEIN, HUMAN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; JO-1 ANTIBODY; MORC3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRIM33 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTISYNTHETASE SYNDROME; ARTICLE; BLOTTING; CHILD; CLINICAL FEATURE; COHEN KAPPA; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOMYOSITIS; FEMALE; HUMAN; IMMUNOPRECIPITATION; ISOTOPE LABELING; K562 CELL LINE; LINE BLOT; MAJOR CLINICAL STUDY; MALE; MYOSITIS; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERUM; STATISTICAL MODEL; BLOOD; IMMUNOASSAY; IMMUNOLOGY; K-562 CELL LINE; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADENOSINE TRIPHOSPHATASES; ADULT; ANTIBODIES, ANTINUCLEAR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOPRECIPITATION; INTERFERON-INDUCED HELICASE, IFIH1; K562 CELLS; MALE; MIDDLE AGED; MYOSITIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 84959490770     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2016.02.017     Document Type: Article

References (32)

1. Aggarwal R., Fertig N., Goudeau D., et al. Anti-transcription intermediary factor 1-gamma autoantibody detection by ELISA and immunoprecipitation in a prospective myositis cohort: predictive value for cancer associated myositis. ACR, 76th annual meeting, S824 2012.
2. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
3. Beneviste O., Druot L., Jouen F., et al. Correlation of antisignal recognition particle autoantibody levels with creatinine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011, 63:1961-1971.
4. Bernstein R.M., Bunn C.C., Hughes G.R.V. Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann. Rheum. Dis. 1982, 41:554-555.
5. Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 1975, 292:403-407.
6. Cavagna L., Nuno L., Scirè C.A., et al. Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study. Medicine (Baltimore) 2015, 94. 10.1097/MD.0000000000001144.
7. Clark G., Reichlin M., Tomasi T.B. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J. Immunol. 1969, 102:117-122.
8. Fiorentino D., Chung L., Zwerner J., et al. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J. Am. Acad. Dermatol. 2011, 65:25-34.
9. Hall J.C., Casciola-Rosen L., Samedy L.-A., et al. Anti-MDA5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res. 2013, 65:1307-1315.
10. Imbert-Maseau A., Hamidou M., Agard C., et al. Antisynthetase syndrome. Joint Bone Spine 2003, 70:161-168.
11. Jeon Y.L., Kim M.H., Lee W.I., Kang S.Y. Comparison of indirect immunofluorescence and line immunoassay for autoantibody detection. Clin. Exp. Rheumatol. 2013, 31:84-90.
12. Koga T., Fujikawa K., Horai Y., et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology 2012, 51:1278-1284.
13. Labirua-Iturburu A., Selva-O'Callaghan A., Vincze M., et al. Anti-PL-7 (antithreonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine 2012, 91:206-211.
14. Lega J.C., Fabien N., Reynaud Q., et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun. Rev. 2014, 13:883-891.
15. LeRoy E.C., Black C., Fleischmajer R. Scleroderma (systemic sclerosis): classification subsets and pathogenesis. J. Rheumatol. 1988, 15:202-205.
16. Love L.A., Leff R.L., Fraser D.D., et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991, 70:360-374.
17. Masi A.T., Rodnan G.P., Medsger T.A., et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980, 23:581-590.
18. Mathews M.B., Bernstein R.M. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983, 304:177-179.
19. Meyer O., Cremer-Legmann F., Haim T., Ryckewaert A. The principal antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. study of 42 cases. Presse Med. 1987, 16:155-158.
20. Muro Y., Sugiura K., Hoshino K., Akiyama M. Disappearance of anti-MDA-5 autoantibodies in clinical amyopathic DM/interstitial lung disease during disease remission. Rheumatology 2012, 51:800-804.
21. Muro Y., Kazumitsu Sugiura K., Akiyama M. A new ELISA for dermatomyositis autoantibodies: rapid introduction of antigen cDNA to recombinant assays for autoantibodies measurement. Clin. Dev. Immunol. 2013, 10.1155/2013/856815. Epub 2013 Dec 12.
22. Nakashima R., Mimori T. Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies. Int. J. Clin. Rheumatol. 2010, 5:523-536.
23. Nishikai M., Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum. 1980, 23:881-888.
24. Satoh M., Tanaka S., Ceribelli A., Calise S.J., Chan E.K. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin. Rev. Allergy Immunol. 2015, (Sep 30).
25. Stone K.B., Oddis C.V., Fertig N., et al. Anti-Jo1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 2007, 56:3125-3131.
26. Tan E.M., Cohen A.M., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
27. Tansley S.L., Betteridge Z.E., McHugh N.J. The diagnostic utility of autoantibodies in adult and juvenile myositis. Curr. Opin. Rheumatol. 2013, 25:772-777.
28. Targoff I.N. Autoantibodies in polymyositis. Rheum. Dis. Clin. N. Am. 1992, 18:455-482.
29. Targoff I.N. Update on myositis-specific and myositis-associated autoantibodies. Curr. Opin. Rheumatol. 2000, 12:475-481.
30. Venables P.J.W., Smith P.R., Maini R.N. Purification and characterization of the Sjögren's Syndrome A and B antigens. Clin. Exp. Immunol. 1983, 54:731-738.
31. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558.
32. Yamasaki Y., Narain S., Hernandez L., et al. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases. Arthritis Res. Ther. 2006, 8:R111.